May 12, 2025 - 14:37

Mike Heffernan has been appointed as the new Chairman of the Board at Avalo Therapeutics, marking a significant leadership change for the company. In addition to this appointment, the company is anticipating the release of topline data from its Phase 2 LOTUS trial for AVTX-009, a treatment aimed at addressing hidradenitis suppurativa, with results expected in 2026.
As of March 31, 2025, Avalo reported a robust cash position of approximately $125 million, which is projected to provide sufficient financial runway into 2027. This funding will allow the company to continue its focus on developing innovative therapies for immune dysregulation, with the potential to extend operations into 2028 if necessary.
These updates reflect Avalo's commitment to advancing its clinical programs and enhancing shareholder value as it navigates the complexities of the biotechnology landscape. The leadership transition and solid financial standing position the company for future growth and success in the coming years.
November 19, 2026 - 01:19
Skydance Unveils New Marketing Leadership Team Following Recent DealSkydance has announced its new marketing leadership team in the wake of the recent Paramount-WBD deal. In a memo from marketing chief Rebecca Mall, the company outlined the strategic direction and...
November 18, 2026 - 06:53
Executives Worry About Democratic Control in TexasA wave of concern has swept through Texas business circles as executives grapple with the implications of a potential Democratic takeover of the state`s executive branch. Many industry leaders fear...
November 17, 2026 - 20:26
Nvidia Posts Quarterly Earnings Amid Leadership ChangesNvidia released its first quarterly earnings report since Jensen Huang stepped down as CEO last week amid allegations of extramarital affairs. The earnings report revealed a mixed bag of results,...
November 17, 2026 - 02:27
Mastering the Algorithm: Key Insights for Business LeadersIn today`s fast-paced market, consumers are still the focal point for consumer packaged goods and retail brands. However, they are increasingly sharing the spotlight with algorithms. As artificial...